ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

IVO Touchstone

315.00
0.00 (0.00%)
26 Apr 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Touchstone LSE:IVO London Ordinary Share GB00B170L953 ORD 3 1/33P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 315.00 305.00 325.00 - 0.00 01:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
0 0 N/A 0

Touchstone Innovations Share Discussion Threads

Showing 1 to 18 of 75 messages
Chat Pages: 3  2  1
DateSubjectAuthorDiscuss
12/1/2011
09:40
sorry XR not XF
chad0x001
11/1/2011
12:43
Why have these apparently stopped trading? has been on my watch list for a bit - am nwe to the game so not sure what XF code means.
chad0x001
19/10/2010
21:38
Imperial Innovations Group (LON:IVO) (IVO 465p/£278.03m)

If you would like to have exposure to venture capital in your portfolio, but are unable to invest directly in a venture capital fund, Imperial Innovations Group (Innovations) may be the solution. Innovations has exclusive access to scientific and technological developments originating from Imperial College London and has accumulated a portfolio of more than 80 companies. Similar to venture capital firms, Innovations is able to invest at a very early stage and at very low valuations. In contrast, Innovations also benefits from having a more flexible and long term time horizon as well as additional income streams such as corporate finance and intellectual property management fees and licence and royalty revenues. Innovations recently announced preliminary results for the year ended 30 July 2010 that showed an increase in net asset value of £5.5m (or 4.4 per cent per share). Portfolio highlights included net realisations of £9.9m including £9.5m gross cash from the sale of Respivert to Centocor, representing a 4.7 times return on a three-year investment. An interesting feature of Innovations' portfolio is the long tail of revenues, even after a realisation. In addition to cash payments, the company will often receive deferred payments and this is not fully reflected in the balance sheet. Innovations' portfolio is focused on opportunities in healthcare, energy, engineering and cleantech. Several portfolio companies have very high potential and Innovations is pleased to observe excellent progress during the year. The ownership percentage in each company is typically high, which should give a "big bang for the buck" if and when successful. The high valuation does not make this a trading stock or a suitable short-term investment, however inclusion in a long-term investment portfolio such as a SIPP could provide excellent and unexpected results.

strollingmolby
19/10/2010
21:37
Imperial Innovations Group (LON:IVO) (IVO 465p/£278.03m)

If you would like to have exposure to venture capital in your portfolio, but are unable to invest directly in a venture capital fund, Imperial Innovations Group (Innovations) may be the solution. Innovations has exclusive access to scientific and technological developments originating from Imperial College London and has accumulated a portfolio of more than 80 companies. Similar to venture capital firms, Innovations is able to invest at a very early stage and at very low valuations. In contrast, Innovations also benefits from having a more flexible and long term time horizon as well as additional income streams such as corporate finance and intellectual property management fees and licence and royalty revenues. Innovations recently announced preliminary results for the year ended 30 July 2010 that showed an increase in net asset value of £5.5m (or 4.4 per cent per share). Portfolio highlights included net realisations of £9.9m including £9.5m gross cash from the sale of Respivert to Centocor, representing a 4.7 times return on a three-year investment. An interesting feature of Innovations' portfolio is the long tail of revenues, even after a realisation. In addition to cash payments, the company will often receive deferred payments and this is not fully reflected in the balance sheet. Innovations' portfolio is focused on opportunities in healthcare, energy, engineering and cleantech. Several portfolio companies have very high potential and Innovations is pleased to observe excellent progress during the year. The ownership percentage in each company is typically high, which should give a "big bang for the buck" if and when successful. The high valuation does not make this a trading stock or a suitable short-term investment, however inclusion in a long-term investment portfolio such as a SIPP could provide excellent and unexpected results.

strollingmolby
07/10/2009
15:37
Imperial Innovations into the black
investinggarden
14/5/2009
18:23
Online Stock Trades - Shares Magazine and Newspaper Stock Picks

SHARES MAGAZINE

Plays:

Sell Barratt Developments at 160p

Buy NetPlay TV at 25.75p

Updates:

Take profits in Sepura

Hold Business Systems Group

Blue Sky Stocks:

Blinkx -- Lombard Medical -- Ceres Power -- Imaginatik -- Antisoma -- Synchronica -- Vyke Communications -- Falklands Oil & Gas -- Imperial Innovations !!!! -- PureCircle

jammytass
02/2/2009
15:49
ceres power wins contract
jammytass
27/1/2009
20:01
About Imperial Innovations

Imperial Innovations combines the activities of technology transfer, company incubation and investment. Our goal is to bring valuable ideas to market either by building businesses or licensing to industry.



*


Imperial Innovations combines the activities of technology transfer, company incubation and investment. Our goal is to bring valuable ideas to market either by building businesses or licensing to industry.

Imperial College London, consistently rated amongst the world's best universities, is our main partner and major source of ideas. We also provide a number of external research intensive organisations including both public and private sector ownership with our commercialisation services.


We are highly experienced in every stage of the route to commercialisation. The services we offer include:

* Technology sourcing
* Intellectual property management
* Commercial assessment of intellectual property
* Market analysis
* Licence negotiation
* Incubation services and space
* Investment

jammytass
27/1/2009
19:30
try there web site
jammytass
27/1/2009
19:26
Think you ought to put some effort into the header, explain a bit about the company perhaps... usually a good start!
and then
27/1/2009
18:50
Doc

jdb is one to ask about Vialogy, he has a thread on TIM.

secretsqu

secretsqu
27/1/2009
18:47
jammytass

You're the only one here - who else is there to ask about shah talukder and Vialogy?

the_doctor
27/1/2009
16:24
all the tec for the future in 1 cmpy this is a must for all tec investors
jammytass
15/1/2009
17:24
on the move . much more to come
jammytass
15/1/2009
17:24
on the move . much more to come
jammytass
17/6/2008
07:56
after many smart investments this group will start to move very soon!!!!!!!!!!!!!!!!
jammytass
26/11/2007
18:35
large stake in i2india is a great move for this group only a matter of time before they strike gold
jammytass
27/4/2007
15:58
--> Hi Hyper Al,

Have you invested?
I've had this on my monitor ever since I came across this:-

"Applied Biosystems was granted a licence by Imperial Innovations for technology which was used in the iTRAQ Reagent Kits. The iTRAQ Reagent Kit is the first set of amine-specific, stable isotope reagents that can label all peptides in up to four different biological samples simultaneously. It provides a flexible solution for quantitative biology research."



Good to see a thread created. Perhaps someone will have to time to look into the company more deeply.

greynag
Chat Pages: 3  2  1

Your Recent History

Delayed Upgrade Clock